Insmed Incorporated (INSM)
$98.56-2.03%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $21.4B
- Beta
- 0.82
- P/E (TTM)
- -25.60
- Short % float
- 6.96%
- Days to cover
- 6.5
- SI change
- +27.8%
- 1W
- -5.08%
- 1M
- -23.84%
- vs SPY 1W
- -5.50%
- vs SPY 1M
- -25.90%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on INSM?
- LOPJLB’s latest quantitative signal on Insmed Incorporated (INSM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INSM in?
- Insmed Incorporated (INSM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Insmed Incorporated (INSM) do?
- Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its develo…